TERIFREC INJECTION

Terifrec Injection is a teriparatide-based medication used in the treatment of osteoporosis in men and postmenopausal women at high risk of fractures. It works by stimulating new bone formation, improving bone density, and strengthening the skeletal structure. Teriparatide injection is commonly prescribed when other osteoporosis treatments are not effective, helping reduce fracture risk and support long-term bone health.

This injection is a recombinant form of parathyroid hormone that activates bone-building cells, increasing bone mass and improving bone strength. Terifrec Injection is usually administered once daily under medical supervision for a specific treatment duration recommended by a healthcare professional. It is widely used in orthopedic and endocrine care to help patients regain bone strength and mobility.

Terifrec Injection is prepared following strict pharmaceutical standards to ensure safety, quality, and reliable therapeutic performance. Proper storage and handling help maintain its effectiveness and stability. It is one of the trusted products in the pharmaceutical segment for osteoporosis management and fracture prevention.

Product Features

• Contains Teriparatide for osteoporosis treatment
• Stimulates new bone formation
• Helps improve bone density and strength
• Reduces the risk of fractures
• Administered under medical supervision

How It Helps

• Builds stronger bones
• Improves bone mineral density
• Reduces fracture risk
• Supports mobility and bone health